Whitepapers

Recent Articles

Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary...

Regulatory Affairs

Acticor Biotech Announces the Enrollment of the First US Patient in its Phase 2/3 Study ACTISAVE for the Treatment of Stroke

Industry News

Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD

Industry News

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO

Regulatory Affairs

Bio-Thera Solutions Announces Enrollment Completed in Phase 1 Study for BAT2022, a Broadly Potent Neutralizing Bi-specific Antibody Against SARS-CoV-2

Industry News

Aura Biosciences to Present Ongoing Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) for the First-Line Treatment of Patients with Early-Stage Choroidal...

Industry News

AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors

Look Who’s On the Move!

Aktana Welcomes New Medical Affairs Lead from IBM Watson Health (Now Merative)

Editor´s Pick

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Regulatory Affairs

Partnering with Patients and Caregivers in Clinical Research

Natalie Yeadon

Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660

Regulatory Affairs

AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer

Look Who’s On the Move!

Janux Therapeutics Appoints Brenda Van Vreeswyk as Head of Human Resources

Look Who’s On the Move!

Alnylam Announces New Management Appointments

Industry News

Janux Therapeutics Appoints Winston Kung to Board of Directors

Look Who’s On the Move!

2021 © Copyright - TPMG

Get a free copy of "Cracking the Generics Code"

Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.